Thermo Fisher Scientific (TMO) Net Margin (2009 - 2026)

Thermo Fisher Scientific has reported Net Margin for 18 years, with the latest figure at 14.65% in Q2 2026.

• Net Margin for Q2 2026 came in at 14.65%, down 25.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 15.19% (down 4.0% YoY), and the FY2025 annual result was 15.17%, up 40.0% from the prior year.
• Net Margin fell to 14.65% in Q2 2026, from 15.12% in the prior quarter.
• Over five years, Net Margin peaked at 18.74% in Q2 2022 and troughed at 12.04% in Q2 2023.
• A 5-year average of 14.82% and a median of 14.79% in 2025 frame the typical range for Net Margin.
• The largest YoY upside for Net Margin was 222 bps in 2023 against a maximum downside of 671 bps in 2023.
• A 5-year view of Net Margin shows it stood at 13.76% in 2022, then gained by 9 bps to 14.97% in 2023, then climbed by 7 bps to 16.06% in 2024, then advanced by 2 bps to 16.37% in 2025, then retreated by 11 bps to 14.65% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 14.65% in Q2 2026, 15.12% in Q1 2026, and 16.37% in Q4 2025.